Two Sigma Advisers’s 9 Meters Biopharma NMTR Stock Holding History

Two Sigma Advisers’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-650	Closed	-$3K	–	2759
2022 Q3	$3K	Buy	+650	New	+$3.22K	﹤0.01%	2514
2022 Q2	–	Sell	-7,205	Closed	-$86K	–	2955
2022 Q1	$86K	Sell	7,205 -335	-4%	-$4.57K	﹤0.01%	2527
2021 Q4	$148K	Buy	7,540 +6,140	+439%	+$137K	﹤0.01%	2361
2021 Q3	$36K	Sell	1,400 -75,725	-98%	-$1.78M	﹤0.01%	2389
2021 Q2	$1.7M	Buy	77,125 +18,140	+31%	+$445K	﹤0.01%	1374
2021 Q1	$1.38M	Buy	58,985 +55,430	+1,559%	+$1.7M	﹤0.01%	1463
2020 Q4	$61K	Sell	3,555 -1,105	-24%	-$18.4K	﹤0.01%	2306
2020 Q3	$76K	Buy	+4,660	New	+$56.5K	﹤0.01%	2294
2018 Q4	–	Sell	-500	Closed	-$68K	–	2500
2018 Q3	$68K	Buy	+500	New	+$85.9K	﹤0.01%	2167

Other funds holding NMTR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

ODFS

O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Two Sigma Advisers's NMTR Position: Q4 2022 in Review

Two Sigma Advisers sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 650 shares — an estimated $3K sold.

Two Sigma Advisers first reported a position in NMTR in Q3 2018 and held it in 9 quarters. The position peaked at $1.7M in Q2 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

Two Sigma Advisers reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
Two Sigma Advisers sold 650 9 Meters Biopharma shares in Q4 2022, an estimated $3K.
Two Sigma Advisers first reported a position in 9 Meters Biopharma in Q3 2018 and held it in 9 quarters.
Two Sigma Advisers's 9 Meters Biopharma position peaked at $1.7M in Q2 2021.
42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.